1. Clinical Drug Development in Epilepsy Revisited: A Proposal for a New Paradigm Streamlined Using Extrapolation

   • Ian Wadsworth
   • Thomas Jaki
   • Lisa V. Hampson

   Current Opinion Open access 13 September 2016 Pages: 1011 - 1017

2. May the Force Be With You: The Light and Dark Sides of the Microbiota–Gut–Brain Axis in Neuropsychiatry

   • Eoin Sherwin
   • Kiran V. Sandhu
   • John F. Cryan

   Leading Article Open access 14 July 2016 Pages: 1019 - 1041

   

3. Tolerability and Safety Profile of Cariprazine in Treating Psychotic Disorders, Bipolar Disorder and Major Depressive Disorder: A Systematic Review with Meta-Analysis of Randomized Controlled Trials

   • Kim S. J. Lao
   • Ying He
   • Esther W. Chan

   Systematic Review 22 August 2016 Pages: 1043 - 1054

   

4. Synaptic Vesicle Glycoprotein 2A Ligands in the Treatment of Epilepsy and Beyond

   • Wolfgang Löscher
   • Michel Gillard
   • Henrik Klitgaard

   Review Article Open access 17 October 2016 Pages: 1055 - 1077

   

5. Novel Levodopa Formulations for Parkinson’s Disease

   • Maria Eliza Freitas
   • Marta Ruiz-Lopez
   • Susan H. Fox

   Review Article 14 October 2016 Pages: 1079 - 1095

6. The Effect of Safety Warnings on Antipsychotic Drug Prescribing in Elderly Persons with Dementia in the United Kingdom and Italy: A Population-Based Study

   • Janet Sultana
   • Andrea Fontana
   • Gianluca Trifirò

   Original Research Article 16 July 2016 Pages: 1097 - 1109

   

7. Treatment for Rheumatoid Arthritis and Risk of Alzheimer’s Disease: A Nested Case-Control Analysis

   • Richard C. Chou
   • Michael Kane
   • Jiang Gui

   Original Research Article 28 July 2016 Pages: 1111 - 1120